Measuring quality of life in psoriasis: The CALIPSO questionnaire

European Journal of Dermatology

Volumn 21, Issue 1, 2011, Pages 67-78

  Sampogna, Francesca ^a   Styles, Irene ^b   Tabolli, Stefano ^a   Abeni, Damiano ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

CALIPSO; Dermatology; Psoriasis; Quality of life; Questionnaire development; Rasch analysis

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COMPREHENSIVE APPRAISAL OF LIFE IMPACT OF PSORIASIS QUESTIONNAIRE; CONSTRUCT VALIDITY; CONTROLLED STUDY; DATA ANALYSIS; DERMATOLOGY; DERMATOLOGY LIFE QUALITY INDEX; FEMALE; HUMAN; IMPACT OF PSORIASIS QUALITY OF LIFE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PSORIASIS; PSORIASIS DISABILITY INDEX; PSORIASIS LIFE STRESS INVENTORY; QUALITY OF LIFE; QUESTIONNAIRE; RASCH ANALYSIS; RATING SCALE; SKINDEX 29; COMPUTER PROGRAM; PSYCHOMETRY;

HUMANS; PSORIASIS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SOFTWARE;

EID: 79957496527     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.1202     Document Type: Article

References (33)

1. Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mork C, et al. Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol 2002; 146: 1006-16.
2. Sampogna F, Chren MM, Melchi CF, Pasquini P, Tabolli S, Abeni D. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol 2006; 154: 325-31.
3. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137: 280-4.
4. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-6.
5. Chren MM, Lasek RJ, Quinn LM, Covinsky KE. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol 1997; 108: 103-7.
6. Inanir I, Aydemir O, Gunduz K, Danaci AE, Turel A. Developing a quality of life instrument in patients with psoriasis: the Psoriasis Quality of Life Questionnaire (PQLQ). Int J Dermatol 2006; 45: 234-8.
7. Finlay AY, Kelly SE. Psoriasis-an index of disability. Clin Exp Dermatol 1987; 12: 8-11.
8. Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol 1995; 75: 240-3.
9. McKenna KE, Stern RS. The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort. J Am Acad Dermatol 1997; 36(3 Pt 1): 388-94.
10. Tennant A, McKenna SP, Hagell P. Application of Rasch analysis in the development and application of quality of life instruments. Value Health 2004; 7(Suppl. 1): S22-6.
11. Abeni D, Picardi A, Pasquini P, Melchi CF, Chren MM. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology 2002; 204: 43-9.
12. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997; 133: 1433-40.
13. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707-13.
14. Gill TM, Feinstein AR. A critical appraisal of the quality of qualityof-life measurements. JAMA 1994; 272: 619-26.
15. Sampogna F, Raskovic D, Guerra L, Pedicelli C, Tabolli S, Leoni L, et al. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol 2008; 159: 351-9.
16. de Korte J, van der Valk PG, Sprangers MA, Damstra RJ, Kunkeler AC, Lijnen RL, et al. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting. Br J Dermatol 2008; 158: 375-81.
17. Sampogna F, Tabolli S, Mastroeni S, Di Pietro C, Fortes C, Abeni D. Quality of life impairment and psychological distress in elderly patients with psoriasis. Dermatology 2007; 215: 341-7.
18. Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159: 997-1035.
19. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132: 236-44.
20. Kent G, al-Abadie M. The Psoriasis Disability Index-further analyses. Clin Exp Dermatol 1993; 18: 414-6.
21. Woo WK, McKenna KE. Combination TL01 ultraviolet B phototherapy and topical calcipotriol for psoriasis: a prospective randomized placebo-controlled clinical trial. Br J Dermatol 2003; 149: 146-50.
22. Fortune DG, Richards HL, Griffiths CE, Main CJ. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002; 41(Pt 2): 157-74.
23. Davidsson S, Blomqvist K, Molin L, Mork C, Sigurgeirsson B, Zachariae H, et al. Lifestyle of Nordic people with psoriasis. Int J Dermatol 2005; 44: 378-83.
24. Sampogna F, Sera F, Abeni D. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 2004; 122: 602-7.
25. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 1989; 262: 907-13.
26. Nijsten T, Unaeze J, Stern RS. Refinement and reduction of the Impact of Psoriasis Questionnaire: classical test theory vs. Rasch analysis. Br J Dermatol 2006; 154: 692-700.
27. Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press, 1960-1980.
28. Streiner D, Norman G. Health measurement scales. Oxford: Oxford University Press, 1989.
29. Wright BD, Stone MH. Best Test Design: Rasch Measurement. Chicago, 1979.
30. Andrich D. Rasch model for measurement. Newbury Park, London, New Delhi: Sage University Paper, 1988.
31. RUMM2030. program. Perth: RUMM Laboratory, 2008.
32. Marais I, Andrich D. Formalizing dimension and response violations of local independence in the unidimensional Rasch model. J Appl Meas 2008; 9: 200-15.
33. Nijsten TE, Sampogna F, Chren MM, Abeni DD. Testing and reducing skindex-29 using Rasch analysis: Skindex-17. J Invest Dermatol 2006; 126: 1244-50.